Pro Tip: Learn how to use HBI Alerts to follow your favorite topics

Business Models and Strategy

 

Elsan’s digital approach to primary care  

Paris-based hospital group Elsan says it will open two “highly digitised” primary care facilities by the end of the year in cooperation with Livi, the developer of the e-health platform owned by the Swedish startup Kry. HBI speaks with Thierry Chiche, CEO at Elsan and Jonathan Ardouin, Managing Director at Livi France, to learn more. 
April 21, 2022

Fresenius Helios launches revolutionary primary care offer

Fresenius Helios plans to become the first and only global health care service player by rolling out its Curalie telehealth plus a prefab diagnostic unit (the Cube) starting in Vietnam in October. Deals are being struck with governments in Ghana and Kenya for the group to offer primary care for €10 per cap. to millions. We talk to Fresenius Helios CEO Franceso de Meo.
April 8, 2022

Interview: Simon Turton, Gensmile

At the height of Covid, NHS-focussed dental practices calmly told HBI that their revenues were covered by government payments, and their dental activity targets had been slashed or temporarily abandoned. It was a good time to have a strong NHS patient bias. HBI speaks to Simon Turton, CEO and co-founder of UK dental chain Gensmile and panellist at HBI 2022, to hear how the tide may be turning in favour of private funding.
April 8, 2022

Interview: Dirk Knüppel, Meine Radiologie

Imaging and radiology is hot at the moment - especially in Germany. The next five years are going to see a huge amount of consolidation according to Dirk Knüppel, CEO at EQT-backed Meine Radiologie & Blikk Holding (MRBH) and HBI 2022 panellist. HBI caught up with him to find out more about his group's plans to expand across Europe.
April 7, 2022

Turkish groups look for lira depreciation workarounds

The Turkish Lira has been consistently depreciating, losing three-quarters of its US dollar value in the last five years. HBI speaks with an operator source, as well as consultants and operators from Turkey, to find out their strategy to hedge against a worsening exchange rate.
April 7, 2022

Interview: Tim Clover, Rayner

HBI catches up with Tim Clover, CEO of UK-based ophthalmic medical products specialist Rayner, ahead of his appearance as a panellist at HBI 2022. He is excited about the Covid bounceback and hot new tech, but warns new regulations will impact heavily on everyone's costs.
March 31, 2022

Infermedica targets the USA for expansion

Infermedica, the Polish health tech start-up, will expand its US investments, thanks to the funding gained in a recent Series B financing round. HBI talks with Miłosz Wiciński, Business Development Executive at Infermedica, to learn more.
March 25, 2022

IHH Healthcare shows growth

Malaysia and Singapore based Asia-focussed IHH Healthcare’s 2021 results show dynamic growth. Turkish groups are being impacted by the depreciation of the lira, but while revenue from domestic patients in Turkish subsidiary Acibadem shrank between 2017 and 2020, it grew in 2021, up 16.9% year-on-year.
March 17, 2022

Will record results for Synlab precipitate Cinven sale?

Almost a year after its IPO, lab giant Synlab has posted strong FY21 results bolstered by Covid, but not, it says, dependant on it. Management say extra cash will be used as a springboard for growth. Could it also lead to private equity majority shareholder Cinven selling its remaining interest?
March 17, 2022
Older posts
Newer posts

Our Services

Company

Resources

Log in
Register
Log in
Register

Our Services

Company

Resources

Find Us